NCT01672359已完成不适用
The Effect of Whole-Food Dietary Supplementation on Cognitive and Immune Functioning and Quality of Life in Healthy Older Adults
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 97
- 试验地点
- 2
- 主要终点
- Cognitive Measures
研究概览
简要总结
A six-month study which investigated the effect of Ginkgo Synergy® and Choline or OPC Synergy® and Catalyn® on cognitive and immune function markers and quality of life among healthy older adults with no history of significant cognitive deficits
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 60 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •60 years of age and older
- •English speaking
- •Not living in a skilled or intermediate care level nursing facility
- •No use of dietary supplements for cognitive functioning two weeks before enrolling in the study and during the length of the trial
- •A Mini-Mental State Exam (MMSE) score ≥ 23
排除标准
- •A cognitive deficit greater than that indicated according to the MMSE score
- •A clinical diagnosis of AD and/or related disorders
- •A psychiatric diagnosis of schizophrenia, other psychotic disorders, bipolar disorder, major depression with psychotic features, delirium, and alcohol or substance abuse/dependence
- •Bleeding disorders
- •Aphasia or sensory, motor, and/or visual disturbances that would have interfered with psychometric tests
- •Gastrointestinal disorders causing impaired absorption of the study supplements
- •Insulin-dependent diabetes
- •Major conditions such as cardiovascular, pulmonary, renal, thyroid, hepatic, gastrointestinal, or seizure
- •Hematologic or oncologic disorders treated with chemotherapy in the previous two years
- •Active chemotherapy or radiation treatment for cancer
- •Current cigarette smoking
- •More than three major medical or psychiatric hospitalizations in the past year
- •Diagnosis of a terminal illness
- •A T score > 70 on the Global Severity Index of the Brief Symptoms Inventory (BSI)
- •A score ≥ 29 on the Beck Depression Inventory-II (BDI) (15)
- •Prescription and OTC sympathomimetic amines and antihistamines within 2 days of an assessment visit
- •Cognition enhancing drugs consumption such as Donepezil, Rivastigmine, Galantamine, and Tacrine
- •Coumadin, tricyclic antidepressants, antipsychotics, and anticonvulsants
- •Cognition-enhancing supplements, herbs, or antioxidants that could not be stopped during the trial
- •Participating in a concurrent trial for drugs, supplements, or treatment that affects behavior or cognitive function
结局指标
主要结局
Cognitive Measures
时间窗: 6 months
The measures included the MMSE, the Stroop Color and Word Test (SCWT), the Trail Making Test Parts A and B (TMT-A, TMT-B), the Controlled Oral Word Association test (COWA), the Digit Symbol subtest of the Wechsler Adult Intelligence Scale, Third Edition (WAIS-III), and the Hopkins Verbal Learning Test-Revised (HVLT-R)
次要结局
- Quality of Life Measures(6 months)
- Immune Function Markers(6 months)
研究者
John E. Lewis
Associate Professor
University of Miami
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Effect of a Food Supplementation With a Combined Food Supplement on Lipid Pattern, Indexes of Non-alcoholic Fatty Liver Disease and Systemic InflammationHypercholesterolemiaNCT06247137University of Bologna90
尚未招募
3 期
To see the effect of diet on constipation in pregnant women.CTRI/2023/06/054284Head of the Department
已完成
不适用
Measuring the impact of dietary supplementation with prebiotics on markers of inflammation in ulcerative colitislcerative ColitisDigestive SystemUlcerative ColitisISRCTN26720438King's College London18
已完成
不适用
To examine the effect of dietary supplementation with fish oils and complex lipids on mitochondrial, physical, and cognitive function, in elderly humans.NL-OMON48470niversiteit Maastricht108
已完成
不适用
Effects of a Combination of Polyphenol-rich Extracts on the Protection of Retinal Cells Against Blue Light in the Prevention of Ocular DiseasesEye AbnormalitiesNCT06004570AronPharma Sp. z o. o.22